New phase III psoriasis data show significant skin clearance with Novartis’ secukinumab
Patient-reported outcomes from Feature and Juncture show high patient satisfaction with secukinumab PFS and AI self-administration…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.